Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a… Ashwin Sapra, Parter and Head, Pharmaceuticals, Life Sciences and Healthcare Practice, Cyril Amarchand Mangaldas Apr 22, 2025 Ashwin Sapra highlights how the US Section 232 investigation into pharma imports marks a significant escalation in Trump-era trade…
CDSCO issues compliance framework for SEZ-to-DTA drug transfers Neha Aathavale Apr 11, 2025 New circular standardises licensing pathway for domestic diversion of SEZ-manufactured drugs; however system-level changes raise…
US eyes pharma tariffs in next trade wave EP News Bureau Apr 4, 2025 Indian pharma exports escape current round of US reciprocal tariffs, but White House signals upcoming policy shift with possible…
